Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Grosset

Showing results (141-150 of 177) with videos related to

Pageof 18
Sort By:
Acta Leprologica|January 1, 1986
[A trial of polychemotherapy of leprosy in the Dakar region. Initial observations on the acceptability of the protocols used]J Millan, M Bodian, J C Naudin, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1992
Sparfloxacin, ethambutol, and cortisol receptor inhibitor RU-40 555 treatment for disseminated Mycobacterium avium complex infection of normal C57BL/6 miceC Perronne, Y Cohen, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1991
Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophagesC Perronne, A Gikas, C Truffot-Pernot, et al.
Lancet (London, England)|September 23, 1995
The challenge of tuberculosis: statements on global control and preventionD A Enarson, J Grosset, A Mwinga, et al.
BMJ (Clinical Research Ed.)|September 4, 1998
Multidrug resistant tuberculosis in France 1992-4: two case-control studiesV Schwoebel, B Decludt, A C de Benoist, et al.
Tubercle|September 1, 1991
Rifabutin in combination with clofazimine, isoniazid and ethambutol in the treatment of AIDS patients with infections due to opportunist mycobacteria. Groupe d'Etude et de Traitement des Infections à Mycobacteries RésistantesB Dautzenberg, C Truffot, A Mignon, et al.
The American Review of Respiratory Disease|March 1, 1984
The management of thirty immunocompromised patients with tuberculosisB Dautzenberg, J Grosset, J Fechner, et al.
Antimicrobial Agents and Chemotherapy|May 27, 2005
Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosisSandeep Tyagi, E Nuermberger, T Yoshimatsu, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|March 17, 2005
A case-control study for multidrug-resistant tuberculosis: risk factors in four European countriesM Casal, M Vaquero, H Rinder, et al.
Infection Control and Hospital Epidemiology|November 4, 1998
Mycobacterium avium complex common-source or cross-infection in AIDS patients attending the same day-care facilityA Carbonne, N Lemaitre, M Bochet, et al.
Pageof 18

Showing results (141-150 of 177) with videos related to

Sort By:
Pageof 18
Acta Leprologica|January 1, 1986
[A trial of polychemotherapy of leprosy in the Dakar region. Initial observations on the acceptability of the protocols used]J Millan, M Bodian, J C Naudin, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1992
Sparfloxacin, ethambutol, and cortisol receptor inhibitor RU-40 555 treatment for disseminated Mycobacterium avium complex infection of normal C57BL/6 miceC Perronne, Y Cohen, C Truffot-Pernot, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1991
Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophagesC Perronne, A Gikas, C Truffot-Pernot, et al.
Lancet (London, England)|September 23, 1995
The challenge of tuberculosis: statements on global control and preventionD A Enarson, J Grosset, A Mwinga, et al.
BMJ (Clinical Research Ed.)|September 4, 1998
Multidrug resistant tuberculosis in France 1992-4: two case-control studiesV Schwoebel, B Decludt, A C de Benoist, et al.
Tubercle|September 1, 1991
Rifabutin in combination with clofazimine, isoniazid and ethambutol in the treatment of AIDS patients with infections due to opportunist mycobacteria. Groupe d'Etude et de Traitement des Infections à Mycobacteries RésistantesB Dautzenberg, C Truffot, A Mignon, et al.
The American Review of Respiratory Disease|March 1, 1984
The management of thirty immunocompromised patients with tuberculosisB Dautzenberg, J Grosset, J Fechner, et al.
Antimicrobial Agents and Chemotherapy|May 27, 2005
Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosisSandeep Tyagi, E Nuermberger, T Yoshimatsu, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|March 17, 2005
A case-control study for multidrug-resistant tuberculosis: risk factors in four European countriesM Casal, M Vaquero, H Rinder, et al.
Infection Control and Hospital Epidemiology|November 4, 1998
Mycobacterium avium complex common-source or cross-infection in AIDS patients attending the same day-care facilityA Carbonne, N Lemaitre, M Bochet, et al.
Pageof 18